Impact of proton beam irradiation of an anatomical subsegment of the liver for hepatocellular carcinoma
from Practical Radiation Oncology
From October 11:
The objective of this research was to elucidate the impact on the prognosis, including the survival prognosis, of proton beam irradiation of an anatomical subsegment of the liver (ASPT) for the treatment of hepatocellular carcinoma (HCC). A total of 110 patients who were diagnosed with HCC were analyzed in this retrospective study. Definitive proton beam therapy was delivered at a dose of 76 Gy in 20 fractions between January 2008 and December 2015.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063